Skip to main content
. 2014 May 14;1:214–223. doi: 10.1016/j.toxrep.2014.03.005

Fig. 5.

Fig. 5

Time–concentration profiles of TBBPA in plasma following A: oral administration, 5 min-24 h (250 mg/kg; N = 3); B: IV administration, 5 min-6 h (25 mg/kg; N = 4). Regression lines show model-predicted data. TBBPA was quantified by UV-detection at 210 nm following separation by HPLC (see Section 2).